These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 8663420)

  • 41. Auto-inhibition and partner proteins, core-binding factor beta (CBFbeta) and Ets-1, modulate DNA binding by CBFalpha2 (AML1).
    Gu TL; Goetz TL; Graves BJ; Speck NA
    Mol Cell Biol; 2000 Jan; 20(1):91-103. PubMed ID: 10594012
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The AML1/ETO fusion protein blocks transactivation of the GM-CSF promoter by AML1B.
    Frank R; Zhang J; Uchida H; Meyers S; Hiebert SW; Nimer SD
    Oncogene; 1995 Dec; 11(12):2667-74. PubMed ID: 8545124
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Role of AML1/Runx1 in the pathogenesis of hematological malignancies.
    Kurokawa M; Hirai H
    Cancer Sci; 2003 Oct; 94(10):841-6. PubMed ID: 14556655
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Physical and functional link of the leukemia-associated factors AML1 and PML.
    Nguyen LA; Pandolfi PP; Aikawa Y; Tagata Y; Ohki M; Kitabayashi I
    Blood; 2005 Jan; 105(1):292-300. PubMed ID: 15331439
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Molecular mechanisms of leukemogenesis by AML1/EVI-1.
    Mitani K
    Oncogene; 2004 May; 23(24):4263-9. PubMed ID: 15156182
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Molecular cloning and characterization of PEBP2 beta, the heterodimeric partner of a novel Drosophila runt-related DNA binding protein PEBP2 alpha.
    Ogawa E; Inuzuka M; Maruyama M; Satake M; Naito-Fujimoto M; Ito Y; Shigesada K
    Virology; 1993 May; 194(1):314-31. PubMed ID: 8386878
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Identification of AML-1 and the (8;21) translocation protein (AML-1/ETO) as sequence-specific DNA-binding proteins: the runt homology domain is required for DNA binding and protein-protein interactions.
    Meyers S; Downing JR; Hiebert SW
    Mol Cell Biol; 1993 Oct; 13(10):6336-45. PubMed ID: 8413232
    [TBL] [Abstract][Full Text] [Related]  

  • 48. AML-2 is a potential target for transcriptional regulation by the t(8;21) and t(12;21) fusion proteins in acute leukemia.
    Meyers S; Lenny N; Sun W; Hiebert SW
    Oncogene; 1996 Jul; 13(2):303-12. PubMed ID: 8710369
    [TBL] [Abstract][Full Text] [Related]  

  • 49. AML1/RUNX1 increases during G1 to S cell cycle progression independent of cytokine-dependent phosphorylation and induces cyclin D3 gene expression.
    Bernardin-Fried F; Kummalue T; Leijen S; Collector MI; Ravid K; Friedman AD
    J Biol Chem; 2004 Apr; 279(15):15678-87. PubMed ID: 14747476
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Conserved cysteine residue in the DNA-binding domain of the bovine papillomavirus type 1 E2 protein confers redox regulation of the DNA-binding activity in vitro.
    McBride AA; Klausner RD; Howley PM
    Proc Natl Acad Sci U S A; 1992 Aug; 89(16):7531-5. PubMed ID: 1323841
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Reduction of a conserved Cys is essential for Myb DNA-binding.
    Guehmann S; Vorbrueggen G; Kalkbrenner F; Moelling K
    Nucleic Acids Res; 1992 May; 20(9):2279-86. PubMed ID: 1594446
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Runt domain partner proteins enhance DNA binding and transcriptional repression in cultured Drosophila cells.
    Fujioka M; Yusibova GL; Sackerson CM; Tillib S; Mazo A; Satake M; Goto T
    Genes Cells; 1996 Aug; 1(8):741-54. PubMed ID: 9077443
    [TBL] [Abstract][Full Text] [Related]  

  • 53. AML1 is functionally regulated through p300-mediated acetylation on specific lysine residues.
    Yamaguchi Y; Kurokawa M; Imai Y; Izutsu K; Asai T; Ichikawa M; Yamamoto G; Nitta E; Yamagata T; Sasaki K; Mitani K; Ogawa S; Chiba S; Hirai H
    J Biol Chem; 2004 Apr; 279(15):15630-8. PubMed ID: 14752096
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Isoforms of the Ets transcription factor NERF/ELF-2 physically interact with AML1 and mediate opposing effects on AML1-mediated transcription of the B cell-specific blk gene.
    Cho JY; Akbarali Y; Zerbini LF; Gu X; Boltax J; Wang Y; Oettgen P; Zhang DE; Libermann TA
    J Biol Chem; 2004 May; 279(19):19512-22. PubMed ID: 14970218
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Multimerization via its myosin domain facilitates nuclear localization and inhibition of core binding factor (CBF) activities by the CBFbeta-smooth muscle myosin heavy chain myeloid leukemia oncoprotein.
    Kummalue T; Lou J; Friedman AD
    Mol Cell Biol; 2002 Dec; 22(23):8278-91. PubMed ID: 12417730
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The chimeric genes AML1/MDS1 and AML1/EAP inhibit AML1B activation at the CSF1R promoter, but only AML1/MDS1 has tumor-promoter properties.
    Zent CS; Mathieu C; Claxton DF; Zhang DE; Tenen DG; Rowley JD; Nucifora G
    Proc Natl Acad Sci U S A; 1996 Feb; 93(3):1044-8. PubMed ID: 8577711
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Functional domains of the t(8;21) fusion protein, AML-1/ETO.
    Lenny N; Meyers S; Hiebert SW
    Oncogene; 1995 Nov; 11(9):1761-9. PubMed ID: 7478604
    [TBL] [Abstract][Full Text] [Related]  

  • 58. AML1 stimulates G1 to S progression via its transactivation domain.
    Bernardin F; Friedman AD
    Oncogene; 2002 May; 21(20):3247-52. PubMed ID: 12082641
    [TBL] [Abstract][Full Text] [Related]  

  • 59. An acute myeloid leukemia gene, AML1, regulates hemopoietic myeloid cell differentiation and transcriptional activation antagonistically by two alternative spliced forms.
    Tanaka T; Tanaka K; Ogawa S; Kurokawa M; Mitani K; Nishida J; Shibata Y; Yazaki Y; Hirai H
    EMBO J; 1995 Jan; 14(2):341-50. PubMed ID: 7530657
    [TBL] [Abstract][Full Text] [Related]  

  • 60. High incidence of somatic mutations in the AML1/RUNX1 gene in myelodysplastic syndrome and low blast percentage myeloid leukemia with myelodysplasia.
    Harada H; Harada Y; Niimi H; Kyo T; Kimura A; Inaba T
    Blood; 2004 Mar; 103(6):2316-24. PubMed ID: 14615365
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.